|
Summary Information: Celldex Therapeutics Inc. NASDAQ:CLDX |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
__The following are links to various summary and news pages for __Celldex Therapeutics Inc. [ CLDX ]. __Note: Some Links might not have information for the company. |
|